BlackRock Inc. - ATEA PHARMACEUTICALS INC ownership

ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 125 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$24,574,506
-14.8%
8,191,502
+6.3%
0.00%0.0%
Q2 2023$28,830,588
+7.0%
7,708,713
-4.1%
0.00%0.0%
Q1 2023$26,939,816
-30.3%
8,041,736
+0.1%
0.00%0.0%
Q4 2022$38,641,481
-13.7%
8,033,572
+2.1%
0.00%
-50.0%
Q3 2022$44,789,000
-14.8%
7,871,121
+6.3%
0.00%0.0%
Q2 2022$52,594,000
+10.0%
7,407,542
+11.8%
0.00%
+100.0%
Q1 2022$47,830,000
-7.5%
6,624,693
+14.6%
0.00%0.0%
Q4 2021$51,684,000
-64.4%
5,781,197
+39.8%
0.00%
-75.0%
Q3 2021$145,035,000
+93.4%
4,136,801
+18.5%
0.00%
+100.0%
Q2 2021$74,985,000
+12.9%
3,490,963
+224.6%
0.00%0.0%
Q1 2021$66,412,000
+20.8%
1,075,504
-18.3%
0.00%0.0%
Q4 2020$54,975,0001,315,8300.00%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,485,638$17,648,0002.07%
EcoR1 Capital, LLC 6,340,639$45,019,0001.55%
CM Management, LLC 200,000$1,420,0001.51%
K2 PRINCIPAL FUND, L.P. 1,606,059$11,403,0001.26%
Cormorant Asset Management, LP 1,547,181$10,985,0000.83%
Privium Fund Management (UK) Ltd 61,284$435,0000.49%
Atom Investors LP 30,911$219,0000.10%
FEDERATED HERMES, INC. 3,588,131$25,476,0000.07%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 347,612$2,468,0000.06%
BALYASNY ASSET MANAGEMENT L.P. 1,799,507$12,777,0000.04%
View complete list of ATEA PHARMACEUTICALS INC shareholders